Trends and Factors Associated With Insurer Approval of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Prescriptions
| Autor: | Doshi, Jalpa A., Li, Pengxiang, Puckett, Justin T., Pettit, Amy R., Raman, Swathi, Parmacek, Michael S., Rader, Daniel J. |
|---|---|
| Zdroj: | In Value in Health February 2020 23(2):209-216 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect